Structure Therapeutics’ obesity pill stacks up with Novo and Lilly; Ascletis also reports early results
Article Title: Structure Therapeutics’ Obesity Pill Stacks Up With Novo and Lilly; Ascletis Also Reports Early Results Publication Date: December 8, 2025 In a recent healthcare development, Structure Therapeutics’ GLP-1 obesity drug has shown promising results, according to a report…